The company increased its revenues by 8% YOY to the level of PLN 76 million, whereas its net profit was PLN 3.8 million. EBITDA reached PLN 7.2 million and increased by PLN 0.1 million (2%) YOY, and in Q2 2014 compared to Q1 the increase was PLN 0.9 milli…
Sajtóinformációk
Aktuális és archív sajtóközlemények, vagyis a Mercator Medical Csoportról szóló legfontosabb tudnivalók és a szervezetünkben történt legfontosabb események áttekintése.
Mercator Medical S.A. increases revenues in 1H 2014
The Mercator Medical S.A. Group is growing strongly
In 2013, consolidated net revenues from the sales of products, goods and materials of the Mercator Medical S.A. Group amounted to over PLN 147 million compared to PLN 132 million in 2012. This means an increase of nearly 12%. The operating result also imp…
Report from Mercator Medical's stock exchange debut
On 21 November, the company made its debut on the main market of the Warsaw Stock Exchange.
Stock Exchange debut on 21.11.2013
On 21 November this year, at 10.00 a.m., Mercator Medical S.A. will make its debut on the main market of the Warsaw Stock Exchange. The company’s debut was preceded by a public offering of shares addressed to institutional and individual investors in Pola…